自决定了乳腺癌中对PRMT5抑制剂的敏感性
Charles Brobbey1, Shasha Yin1, Liu Liu1
1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA.
Scientific reports
|July 3, 2023
概括
阻断自会增加癌细胞对PRMT5抑制剂的敏感性. PRMT5通过甲基化ULK1来调节自,这表明PRMT5和自的联合抑制用于癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 蛋白质氨酸甲基转移酶5 (PRMT5) 是一种潜在的癌症标,在临床试验中使用了抑制剂.
- 对于PRMT5抑制剂有效性的调节还不清楚.
- 抑制PRMT5可以触发癌细胞中的细胞保护性自.
研究的目的:
- 调查自如何影响对PRMT5抑制剂的敏感性.
- 为了阐明PRMT5介导的自调节的分子机制.
- 为在癌症治疗中结合PRMT5和自抑制剂提供理由.
主要方法:
- 对PRMT5.5的基因切除和药理抑制.
- 对PRMT5抑制剂的自诱导和敏感性的评估.
- 在R532中通过PRMT5.5对ULK1单甲基化的分析.
主要成果:
- 在三阴性乳腺癌中,自阻塞增强了细胞对PRMT5抑制剂的敏感性.
- 抑制PRMT5会诱导细胞保护性自.
- 在R532中,PRMT5直接单甲基化ULK1,抑制ULK1的激活和自.
- ULK1 抑制通过阻断自,使细胞对PRMT5 抑制敏感.
结论:
- 自是决定细胞对PRMT5抑制剂反应的关键因素.
- PRMT5通过ULK1甲基化调节自,揭示了一个新的机制.
- 结合PRMT5和自抑制剂可能是癌症的有希望的治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.6K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
